[Studies on meiotic delay and aneuploidies induced by colcemid (COM) in male mouse germ cells]

Area of Science:

• Reproductive toxicology
• Cytogenetics
• Mammalian reproductive biology

Context:

• Colcemid (COM) is a known antimitotic agent.
• Aneuploidy is a significant cause of infertility and birth defects.
• Understanding the effects of antimitotic agents on male meiosis is crucial for reproductive risk assessment.

Purpose:

• To investigate the potential of Colcemid (COM) to induce meiotic delay and aneuploidy in male mouse germ cells.
• To determine the dose-dependent and time-course effects of COM on meiosis.
• To elucidate the mechanisms underlying COM-induced meiotic alterations.

Summary:

• Single intraperitoneal injection of 1 mg/kg Colcemid (COM) in male mice induced significant meiotic delay, evidenced by altered ratios of meiotic metaphase II (MMII) to meiosis I (MI) cells.
• Despite causing meiotic delay, COM did not demonstrate aneugenicity, failing to induce aneuploidies in male mouse germ cells under the tested experimental conditions.
• The study discusses potential mechanisms for COM-induced meiotic delay and the absence of aneuploidy induction.

Impact:

• Provides critical data on the reproductive safety of Colcemid in male mammals.
• Contributes to the understanding of mechanisms underlying meiotic delay and aneuploidy induction.
• Informs risk assessment for exposure to antimitotic agents during male gametogenesis.